Filing Details
- Accession Number:
- 0001555280-21-000148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 16:59:06
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 16:59:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1567824 | Ramon Juan Alaix | C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-19 | 133,070 | $73.24 | 347,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-19 | 67,041 | $160.17 | 280,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-19 | 63,029 | $160.89 | 217,307 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-19 | 3,000 | $161.76 | 214,307 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-02-19 | 133,070 | $0.00 | 133,070 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 110,192 | No | 4 | M | Direct |
Footnotes
- The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.48 to $160.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.48 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $161.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
- 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option.
- Each option vests on the third anniversary of the date of grant.
- Each option expires on the tenth anniversary of the date of grant.
- 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.
Billionaire Hedge Funds
